Early Access — free while we kick the tires
EdgarHawk

Fischer Laurent

CEO, PRESIDENT AND DIRECTOR

Director Officer
1 filing analyzed · 1 company · Latest 2025-12-08

Companies

Company Buys Sells Direction
Adverum Biotechnologies, Inc. ADVM 2 0 Net buying

Activity

December 2025
high
Buy
128,699 shares
$553,917
Significance 6/10

ADVM CEO Fischer Laurent purchased 128.7K shares for $553.9K across 2 transactions, raising stake 176.8%

Fischer Laurent, as CEO and President, executed two separate purchases totaling 128,699 shares for $553,916.74, increasing his holdings from 72,814 shares to 201,513 shares—a 176.8% increase. The blended average purchase price of $4.30 sits slightly below the current price of $4.36, and the stock is -31.1% from its 52-week high of $6.33. Notably, Adverum is unprofitable with negative $47,652,000.00 net income over the most recent full fiscal year and zero quarterly revenue, alongside a steep -72.2% annual revenue contraction. The CEO's substantial equity accumulation at this juncture—when the company faces severe operational headwinds and the stock trades near the lower half of its 52-week range—merits investor attention regarding conviction and forward expectations.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access